Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 368 of 5804
-
One-Time radiation procedure could transform cervical cancer care
Disease control Not yet recruitingBackground and Rationale: Locally advanced cervical cancer remains a major public health concern worldwide and in France. Standard-of-care management involves concurrent chemoradiotherapy followed by brachytherapy, which is critical for local tumour control and survival. Convent…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy targets blood cancer relapse
Disease control Not yet recruitingThis is a French multicenter open label non-randomized Phase II trial evaluating the efficacy and tolerance of a combination of oral zanubrutinib and BGB-11417 in subjects aged 18 years and older with previously treated Waldenström macroglobulinemia (WM) who require therapy accor…
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis study is an open-label, controlled, multicenter phase III clinical trial designed to evaluate whether the use of iodine-125 radioactive seed markers can improve treatment response for patients with early or locally advanced breast cancer undergoing neoadjuvant therapy. Neoa…
Phase: PHASE3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy aims to cut disability after 'silent' strokes
Disease control Not yet recruitingThe goal of this multicenter, double-blind, 2×2 factorial randomized controlled trial is to evaluate the efficacy and safety of isosorbide mononitrate, butylphthalide, and their combination in reducing disability in patients with acute lacunar stroke.
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could your own immune cells fight advanced cancer? new trial aims to find out
Disease control Not yet recruitingThe autologous immune cell induction technology used in this project involves transforming peripheral blood mononuclear cells (PBMC) into autologous DC cells, NK cells, CIK cells and other immune cells through cytokine induction, and then re-administering them to the patients. Th…
Phase: PHASE1, PHASE2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis is a prospective, single-arm, multi-center Phase II clinical trial designed to evaluate the efficacy and safety of neoadjuvant therapy with SHR-A1811 in combination with Adebelimumab in patients with resectable, early-stage non-small cell lung cancer (NSCLC) harboring HER2 a…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New ventilator method may save fragile preemies from breathing tubes
Disease control Recruiting nowMany extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant…
Phase: NA • Sponsor: Michelle Baczynski • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Aggressive combo therapy takes on tough brain cancer
Disease control Recruiting now\*\*Brief Summary\*\* The goal of this clinical trial is to learn whether intensified adjuvant treatment is safe and may help delay disease progression in adults with high-risk newly diagnosed glioblastoma. High-risk newly diagnosed glioblastoma in this study includes glioblasto…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a smart device at home tame Post-Surgery pain and prevent chronic pain?
Disease control Recruiting nowAcute postoperative pain (APOP) is a major public health problem, affecting nearly 10 million patients in France each year. Effective analgesic therapy in the first postoperative week is a key factor in reducing early postoperative morbidity and mortality. Poorly controlled APOP …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Timing is everything: new trial tests surgery before or after immunotherapy for kidney cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the timing of surgery (cytoreductive nephrectomy) improves outcomes when combined with immunotherapy (ipilimumab and nivolumab) in adults with metastatic clear cell renal cell carcinoma. The main questions this study aims to an…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Quantum leap in cancer detection: AI blood test could slash unnecessary biopsies
Diagnosis Not yet recruitingThis research project aims to develop a novel blood testing method integrating cutting-edge quantum sensing and artificial intelligence technologies to achieve precise, non-invasive early diagnosis of prostate cancer. The research will employ quantum sensors to perform ultra-high…
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New drug aims to shield heart and kidneys from major events
Disease control Recruiting nowThe purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for liver cancer patients: 4-drug combo targets untreatable tumors
Disease control Not yet recruitingThis study is a single arm, single center, open label clinical trial. Recruit 34 subjects who meet the inclusion criteria and receive hepatic artery chemoembolization (TACE) and stereotactic body radiotherapy (SBRT) combined with immune checkpoint inhibitors and donafenib treatme…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Brain zaps aim to unlock movement in Locked-In patients
Symptom relief Not yet recruitingThis study was a multicenter randomized double-blind, sham controlled trial initiated by Zhujiang Hospital of Southern Medical University. It is planned to recruit 72 eligible patients with atresia syndrome and randomly divide them into four groups according to the ratio of 1:1:1…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New combo aims to tame advanced cervical cancer with fewer side effects
Disease control Not yet recruitingThis study is a prospective, randomized, parallel investigation aimed at evaluating different doses of famitinib malate (20mg, 15mg, or 10mg, once daily, respectively) by analyzing the pharmacokinetics, efficacy, safety, and tolerability of famitinib malate combined with camreliz…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a common drug prevent brain damage after a stroke?
Disease control Not yet recruitingThe investigators propose to conduct a multicenter randomized trial to test whether cilostazol reduces the incidence of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) and improves patients' neurological prognosis, while assessing its safety.
Phase: PHASE3 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Cooling helmet may shield brain from Post-Surgery mental decline
Disease control CompletedPostoperative cognitive dysfunction, or POCD, is a decline in thinking, memory, attention, or executive function that may occur after surgery and anesthesia. Patients undergoing open heart surgery with cardiopulmonary bypass may have a higher risk of POCD because of changes in bl…
Phase: NA • Sponsor: Indonesia University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New immunotherapy combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingThis study is a prospective, II Phase clinical trial designed to evaluate the efficacy and safety of ivonescimab as monotherapy or in combination with platinum-based chemotherapy in the perioperative treatment of resectable non-small cell lung cancer (NSCLC). Patients are strati…
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a lung cancer drug treat rare tumors? new trial aims to find out
Disease control Recruiting nowThis clinical trial is looking at a drug called entrectinib. Entrectinib is approved as standard of care treatment for adult patients with non-small cell lung cancer (NSCLC) which have a particular molecular alteration called ROS1-positive, and patients 12 years old or above with…
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug duo aims to shrink lung tumors before surgery
Disease control Not yet recruitingTo evaluate the safety and efficacy of SYS6010 combined with osimertinib as neoadjuvant therapy for patients with resectable EGFR mutation non-squamous non-small cell lung cancer.
Phase: PHASE2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC